Respiratory & Influenza Vaccines

Vaccines targeting respiratory pathogens aim to prevent infections caused by influenza viruses, respiratory syncytial virus (RSV), and other respiratory viruses. Research focuses on improving vaccine efficacy, formulation, and delivery methods to enhance immune protection. Strategies include strain selection, adjuvant use, and seasonal immunization programs to reduce disease burden. Efforts also address challenges such as viral mutation, vaccine coverage, and population-specific immune responses. Advancements in respiratory vaccine development help decrease hospitalizations, limit outbreaks, and improve public health outcomes worldwide.

    Related Conference of Respiratory & Influenza Vaccines

    March 12-13, 2026

    8th International Conference on Digital Health

    London, UK
    April 08-09, 2026

    5th International Congress on Global Healthcare

    Vienna, Austria
    April 20-21, 2026

    7th Global Summit on Digital Therapeutics

    Barcelona, Spain
    April 27-28, 2026

    8th World Summit on Women's Health and Cancer Awareness

    Vancouver, Canada
    June 01-02, 2026

    2nd International Congress on Primary Health and Safety

    Zurich, Switzerland
    June 15-16, 2026

    8th World Conference on Vaccine and Immunology

    Paris, France
    July 13-14, 2026

    13th World congress on Hospice and Palliative care

    Amsterdam, Netherlands
    July 23-24, 2026

    37th European Heart and Heart Failure Congress

    Paris, France
    August 27-28, 2026

    22nd Global Biomarkers and Clinical Research Summit

    Paris, France
    October 19-20, 2026

    6th Euro-Global Summit on Probiotics & Nutraceuticals

    Paris, France
    December 16-17, 2026

    7th Global Summit on Public Health

    Amsterdam, Netherlands

    Respiratory & Influenza Vaccines Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in